Keranetics, LLC
Winston-Salem, NC · Founded 2008 · CIK 0001444763 · Medtech · Private
KeraStat®, a topical burn wound treatment combining keratin and halofuginone to accelerate healing and prevent scarring
keranetics.com →- Grants
- $2.7M
- 3 awards
- Sector median: 1
- Raised
- $9.9M
- 4 Form D · Dec 2016
- 117 months since last filing
- Contracts
- $8.4M
- 8 awards · Defense, Agriculture, Health and Human S
- #79 of 4531 in medtech
- Patents
- 9
- 2 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I Osd 2009.3 Log. 10012009 | $849,254 | |
| Private capital raised | Form D · SEC | $3,499,225 | |
| Federal contract | Department of Defense · SBIR Phase I (O103-H03-3021) | $1,149,844 | |
| Federal contract | Department of Defense · SBIR Phase I Army 2011.2 Log #11255018 | $901,542 | |
| Private capital raised | Form D · SEC | $4,714,000 | |
| Federal contract | Department of Defense · Osd SBIR Phase I Proposal #0112-H12-3023 | $149,478 | |
| Federal contract | Department of Agriculture · Purchased Pct Shredder SG3 W/pulse Tube (coral) For Cphst - Beltsville, Md 20705/PER Vessela Mavrodieva. | $3,087 | |
| Federal contract | Department of Health and Human Services · Contract For Manufacture, Sterilization And Qc Of A Research Gade Kerastat Burn Gel With Development Of A Comprehensive Regulatory Strategy For Cutaneous Radiation Insury (cri) | $4,071,956 | |
| Federal contract | Department of Defense · Igf::ot::igf SBIR Phase I Dhp 13.2 H132-016-0106 | $1,149,642 | |
| Federal contract | Department of Defense · Army Phase I Proposal A141-048-0987 | $149,686 | |
| Private capital raised | Form D · SEC | $1,655,000 | |
| Federal grant | Department of Defense · Phase II · Spatiotemporally Controlled Keratin Biomaterial Delivery System for Functional Tissue Regeneration | $999,999 | |
| Federal grant | Department of Defense · Phase II · Development of Biocompatible Dressings for the Delivery of Analgesics to Burn Wounds | $998,790 | |
| Private capital raised | Form D · SEC | $1,250,000 | |
| Federal grant | Department of Defense · Phase II · KeraStat(R) Burn Gel and Halofuginone to Prevent Scar Contracture after Burn Injuries | $699,140 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 76 | QOOLABS INC | $8.8M | — |
| 77 | SCIGLOB INSTRUMENTS & SERVICES LLC | $8.8M | — |
| 78 | MYOMO INC | $8.6M | $6.8M |
| 79 | Keranetics, LLC | $8.4M | $9.9M |
| 80 | ViewRay, Inc. | $8.2M | $69M |
| 81 | Aethlon Medical, Inc. | $8.1M | $22M |
| 82 | LIFEWARE LABS LLC | $8.1M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard Blank, Jr.Director
- J. CraftDirector
- Donald FlowDirector
- William HawkinsDirector
- Charles JohnsonDirector · Executive Officer · Promoter
- Graeme KeithDirector
- Graeme Keith, Jr.Director
- L KomanDirector · Executive Officer
- Mark Van DykeDirector · Executive Officer
- Kim WestmorelandDirector · Executive Officer · Promoter
Patents
- White Keratin Compositionsgranted
- Keratin Compositions Comprising Halofuginonegranted
- White Keratin Compositionsapplication
- Keratin Compositions Comprising Halofuginoneapplication
- Low Protein Percentage Gelling Compositionsapplication
- Methods For Extracting Keratin Proteinsapplication
- Dermal Fillers Comprising Keratin Biomaterialsapplication
- Angiogenesis Promoted By Alpha-keratoseapplication
- Dermal Fillers Comprising Keratin Biomaterialsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.